![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Zhejiang Raybow Pharmaceutical Co., Ltd. Taizhou City Cn, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Carbamazepine, Process B, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-135 - Rev 00
This Chemical Type CEP, issued on May 30, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 543 associated with this CEP further emphasizes